extractX Ltd. Partner Receives GMP-PIC/S by Thai FDA

extractX Ltd. Partner Receives GMP-PIC/S by Thai FDA

Niagara, ON May 1, 2023

extractX Ltd. (“extractX” or the “Company”), announced today that Salus Bioceutical (Thailand) Co., Ltd. (Salus) utilizing extractX mobile lab technology has achieved certified Good Manufacturing Practice – Pharmaceutical Inspection Co-Operation Scheme (GMP – PIC/S) by the Thai Food and Drug Administration (FDA) for manufacturing the ingredients used in herbal medicine products. In addition, Salus has become the first company in Thailand to be certified by the Thai Industrial Standards Institute (TISI). Please see the following letter for additional information.

Acknowledgement of Achievement of Certified Standards

pdf icon

extractX is proud to provide Salus with EU-GMP and GMP-PIC/S certifiable equipment and processes, along with ongoing support in their achievement of these certifications.

We would like to congratulate Salus for becoming the first TISI certified and PIC/S compliant producer in Thailand. With PIC/S stated purpose of promoting harmonization of GMP standards globally, we expect our GMP / EU-GMP certifiable mobile laboratories, processes and ongoing support will help more manufacturers achieve the highest quality extraction to serve local and global market opportunities

– Albert Iannantuono, Co-CEO of extractX Ltd.

Salus is extremely proud of its achievements, and are thankful to extractX for its support, partnership, well-designed technology and processes, which contributed to Salus achievement of these important certifications. We see a mutually prosperous relationship for the long term,” commented Tanadee Pantumkomon, Chief Executive Officer and Director Salus Bioceutical (Thailand) Co., Ltd.

About extractX Ltd.

extractX designs, builds, and assists in operations of industrial scale self-contained mobile extraction laboratories equipped with the most effective and reliable equipment, allowing for efficient 24/7 operation, and unlimited scalability to meet the demand of any size operation. Built to GPP/GMP/EU GMP standards, extractX purpose builds mobile extraction laboratories to service biomass cultivators and producers wherever and whenever the service is needed, onsite and on demand anywhere in the world.

For further information

Certain statements contained herein constitute forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Such statements include, without limitation, statements regarding business and financing, business trends and future operating revenues and expenses. Statements regarding the aforementioned are based on several assumptions and are not to be considered fact. Although extractX Ltd. believes that the statements are reasonable, it can give no assurances that such expectation will prove to be correct. Investors are cautioned that any forward-looking statements made by extractX Ltd. contain no guarantee of future performance and that actual results may differ materially from those set forth in the forward-looking statements. For additional information see the reports filed by the company in its securities filings with applicable securities regulators (currently available at www.sedar.com). Unless otherwise required by applicable securities laws, extractX Ltd. disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For further information contact:

Albert Iannantuono, Co-CEO
extractX Ltd.
1027 South Pelham St Unit 2,
Welland, Ontario, L3C 3E2
Tel: (905) 327-5313
Website: www.extractx.com